ALEXIS ERLACH: Open Payments
NPI 1003486192 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 36 payments from 16 companies in 2025. Trend: 2023 $644 · 2024 $1,487 · 2025 $883
Food & beverage: $809Education: $74
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $139 |
| Incyte Corporation | 1 | $123 |
| ABBVIE INC. | 6 | $119 |
| Lilly USA, LLC | 5 | $119 |
| LEO Pharma Inc. | 3 | $63 |
| UCB, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: DUPIXENT, OPZELURA, TALTZ, SKYRIZI, Bimzelx, ADBRY, Zoryve, JUBLIA.
Industry payments across NV — which companies pay providers there.
